J.P. Morgan Securities LLC Form 8.1a - Pfizer Inc (6868G)

TIDMPFZ

RNS Number : 6868G

J.P. Morgan Securities LLC

23 November 2015

Ap9

APPENDIX 3 DISCLOSURE FORMS

FORM 8.1(a)&(b)(i)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

   1.       KEY INFORMATION 
 
 Name of person dealing  J.P. Morgan Securities 
  (Note 1)                LLC - PCS 
=======================  ====================== 
 Company dealt in        Pfizer Inc. 
=======================  ====================== 
 Class of relevant       Common Stock 
  security to which 
  the dealings being 
  disclosed relate 
  (Note 2) 
=======================  ====================== 
 Date of dealing         20 November 2015 
=======================  ====================== 
 
   2.         INTERESTS AND SHORT POSITIONS 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 
                                           Long               Short 
============================  ==================  =================== 
                               Number       (%)    Number       (%) 
============================  ===========  =====  ===========  ====== 
 (1) Relevant securities      346,349 0.01 
============================  ==================  =================== 
 (2) Derivatives (other 
  than options) 
============================  ==================  =================== 
 (3) Options and agreements 
  to purchase/sell 
============================  ==================  =================== 
 Total                        346,349 0.01 
============================  ==================  =================== 
 
 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 
 Class of relevant                           Long                Short 
  security: 
=============================  ====================  ===================== 
                                Number         (%)    Number         (%) 
=============================  ===========    =====  ===========    ====== 
 (1) Relevant securities 
=============================  ====================  ===================== 
 
   (2) Derivatives (other 
   than options) 
=============================  ====================  ===================== 
 
   (3) Options and agreements 
   to purchase/sell 
=============================  ====================  ===================== 
 Total 
=============================  ====================  ===================== 
 
 

Ap10

   3.       DEALINGS (Note 4) 
   (a)      Purchases and sales 
 
 Purchase/sale         Number of relevant       Price per 
                        securities               unit (Note 
                                                 5) 
==============  =========================  ================ 
    Sales                  18                  32.3200 
                            2                   32.4501 
==============  =========================  ================ 
 
   (b)      Derivatives transactions (other than options transactions) 
 
 Product     Nature of      Number of relevant   Price 
  name,       transaction    securities           per unit 
  e.g. CFD    (Note 6)       (Note 7)             (Note 
                                                  5) 
==========  =============  ===================  ========== 
 
 
   (c)      Options transactions in respect of existing relevant securities 
   (i)       Writing, selling, purchasing or varying 
 
 Product   Writing,       Number           Exercise   Type,       Expiry   Option 
  name,     selling,       of securities    price      e.g.        date     money 
  e.g.      purchasing,    to which                    American,            paid/received 
  call      varying        the option                  European             per unit 
  option    etc.           relates                     etc.                 (Note 
                           (Note                                            5) 
                           7) 
========  =============  ===============  =========  ===========  ======  =============== 
 
 
   (ii)      Exercising 
 
 Product name,         Number of securities       Exercise price 
  e.g. call                                        per unit (Note 
  option                                           5) 
==============  ===========================  ==================== 
 
 
   (d)      Other dealings (including transactions in respect of new securities) (Note 4) 
 
 Nature of            Details       Price per 
  transaction                        unit 
  (Note 8)                           (if applicable) 
                                     (Note 5) 
=============  ==============  ===================== 
 
 

Ap11

   4.       OTHER INFORMATION 

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any

relevant securities to which any derivative referred to on this form is referenced. If none, this

should be stated.

   Is a Supplemental Form 8 attached? (Note 9)                                            NO 
 
 Date of disclosure         23 November 2015 
=========================  =================== 
 Contact name                   Tung T Le 
=========================  =================== 
 Telephone number             0207 742 7272 
=========================  =================== 
 Name of offeree/offeror      Allergan plc 
  with which acting 
  in concert 
=========================  =================== 
 Specify category          Adviser to Allergan 
  and nature of acting             plc 
  in concert status 
=========================  =================== 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

ISEEAXFDASKSFFF

(END) Dow Jones Newswires

November 23, 2015 12:58 ET (17:58 GMT)